FDA Inspection 1034270 — Radnostix

Radnostix — FEI 3003350319

The FDA completed an inspection of Radnostix on December 8, 2017 in Idaho Falls, ID. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 8, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Idaho Falls, ID (United States)